Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial - Concepedia

Concepedia

Publication | Open Access

Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial

DOI Full Paper Access

219

Citations

39

References

2017

Year

Derek Alderson, David Cunningham, Matthew Nankivell, Jane Blazeby, S M Griffin, A. Crellin, Heike I. Grabsch, Rupert Langer, Susan Pritchard, Alicia Okines,

The Lancet Oncology

References

	Year	Citations

Page 1